Hasenclever Lia, Paranhos Julia, Costa Cíntia Reis, Cunha Gabriel, Vieira Diego
Instituto de Economia, Universidade Federal do Rio de Janeiro. Avenida Pasteur 250 Urca sala 130 22290-250 Rio de Janeiro RJ Brasil.
Cien Saude Colet. 2017 Aug;22(8):2559-2569. doi: 10.1590/1413-81232017228.29422016.
The purpose of this article is to discuss and analyze the development challenges of the medicinal plants and phytotherapics industry in Brazil. This industry represents an excellent alternative to face the paradox of abundance that exists in the health area. The methodology adopted was a field research, using semi-structured questionnaires with companies, researchers and public managers to evaluate their development between 2009 and 2015 and to point out the most serious problems faced. The results observed indicate that the main challenges found were the regulation of law on the access to the genetic patrimony in the research area, and to bring into harmony the rules in the entire chain of medicinal plants and phytotherapics production area. The slow implementation pace of public policies for the industry shows a setback regarding both productive and research activities with medicinal plants and phytotherapics in the period.
本文旨在探讨和分析巴西药用植物与植物疗法产业的发展挑战。该产业是应对健康领域存在的丰富性悖论的绝佳选择。所采用的方法是实地研究,通过对公司、研究人员和公共管理人员使用半结构化问卷,以评估他们在2009年至2015年期间的发展情况,并指出所面临的最严重问题。观察到的结果表明,发现的主要挑战是研究领域获取遗传资源的法律监管,以及使药用植物和植物疗法生产领域整个链条中的规则保持协调一致。该产业公共政策实施步伐缓慢,表明在此期间药用植物和植物疗法的生产及研究活动均遭遇挫折。